Adenosine primes the opening of mitochondrial ATP-sensitive potassium channels: a key step in ischemic preconditioning?

Circulation. 2000 Aug 15;102(7):800-5. doi: 10.1161/01.cir.102.7.800.

Abstract

Background: Adenosine can initiate ischemic preconditioning, and mitochondrial ATP-sensitive potassium (K(ATP)) channels have emerged as the likely effectors. We sought to determine the mechanistic interactions between these 2 observations.

Methods and results: The mitochondrial flavoprotein oxidation induced by diazoxide (100 micromol/L) was used to quantify mitochondrial K(ATP) channel activity in intact rabbit ventricular myocytes. Adenosine (100 micromol/L) increased mitochondrial K(ATP) channel activity and abbreviated the latency to mitochondrial K(ATP) channel opening. These potentiating effects were entirely prevented by the adenosine receptor antagonist 8-(p-sulfophenyl)-theophylline (100 micromol/L) or by the protein kinase C inhibitor polymyxin B (50 micromol/L). The effects of adenosine and diazoxide reflected mitochondrial K(ATP) channel activation, because they could be blocked by the mitochondrial K(ATP) channel blocker 5-hydroxydecanoate (500 micromol/L). In a cellular model of simulated ischemia, adenosine mitigated cell injury; this cardioprotective effect was blocked by 5-hydroxydecanoate but not by the surface-selective K(ATP) channel blocker HMR1098. Moreover, adenosine augmented the cardioprotective effect of diazoxide. A quantitative model of mitochondrial K(ATP) channel gating reproduced the major experimental findings.

Conclusions: Our results support the hypothesis that adenosine receptor activation primes the opening of mitochondrial K(ATP) channels in a protein kinase C-dependent manner. The findings provide tangible links among various key elements in the preconditioning cascade.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Adenosine / pharmacology*
  • Animals
  • Decanoic Acids / pharmacology
  • Diazoxide / pharmacology
  • Enzyme Inhibitors / pharmacology
  • Flavoproteins / metabolism
  • Hydroxy Acids / pharmacology
  • Ischemic Preconditioning*
  • Membrane Proteins / drug effects*
  • Membrane Proteins / metabolism*
  • Oxidation-Reduction / drug effects
  • Polymyxin B / pharmacology
  • Potassium Channels
  • Protein Kinase C / antagonists & inhibitors
  • Protein Kinase C / physiology
  • Purinergic P1 Receptor Antagonists
  • Rabbits
  • Theophylline / analogs & derivatives
  • Theophylline / pharmacology
  • Time Factors

Substances

  • Decanoic Acids
  • Enzyme Inhibitors
  • Flavoproteins
  • Hydroxy Acids
  • Membrane Proteins
  • Potassium Channels
  • Purinergic P1 Receptor Antagonists
  • mitochondrial K(ATP) channel
  • 5-hydroxydecanoic acid
  • 8-(4-sulfophenyl)theophylline
  • Theophylline
  • Protein Kinase C
  • Polymyxin B
  • Adenosine
  • Diazoxide